Study to Compare Contrast-Enhanced Ultrasound, Contrast-Enhanced Dual Energy Mammography, and Contrast-Enhanced Breast MR for Early Breast Cancer Detection
About this study
The purpose of this study is to determine whether contrast-enhanced ultrasound (CEUS) can be used in diagnostic evaluation of breast lesions that cannot be seen using contrast-enhanced MRI (CEMR) and contrast- enhanced dual energy mammography (CEDM). If so, patients can undergo US guided biopsy which is more comfortable for patients and more cost effective.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Patients, greater than 30 years of age.
- In good general health as evidenced by medical history.
- BIRADS 4 or 5 suspicious breast lesions who are scheduled for breast biopsy.
- Patients who are less than 30 years of age.
- Have known or suspected cardiac shunts.
- Have history of hypersensitive allergic reactions to any imaging contrast agents.
- Pregnant (a urine pregnancy test will be given at no cost to the patient).
- Are nursing babies.
- Poor renal function.
- Are unwilling or unable (such as having a pacemaker) to undergo a CEMR.
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.